Amarin Corp Plc (AMRN)

[sstyles]

Correct Waxman is giving the SC a middle ground if they decide not to take the case he is saying at a minimum remand this case so the proper legal framework can be applied (Graham). It is a good strategy because it allows the SC to still do something if they decide not to take the case up.

His opening directly hits at the public policy implications of stifling innovation via research and development and how much Amarin invested in Vascepa....it is telling the SC hey you really need to look at what happened here. He also draws reference to the amicus briefs.

The SC knows Waxman is the expert on patent litigation. Fingers crossed.